This inventor holds 26 USPTO granted patents and 5 published patent applications and 16 EPO patents, primarily in Kinase Inhibitors. Top assignees: Bristol-Myers Squibb Compnay, Other. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kothanur, IN (2013)
- Bengaluru, IN (2011 - 2024)
Company Filing History:
25 out of 3,742 
1 out of 834,513 Years Active: 2011-2026
Areas of Expertise:
Title: Satheesh Kesavan Nair: Innovator and Inventor in Pharmaceutical Development
Introduction
Satheesh Kesavan Nair is a prominent inventor based in Bengaluru, India, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 23 patents, he focuses on developing innovative compounds that have the potential to address critical health issues.
Latest Patents
Among his recent inventions are two notable patents. The first patent involves Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors. This disclosure presents compounds that inhibit Gal-3 and includes pharmaceutically acceptable salts, compositions comprising such compounds, and methods for making and using these innovative compounds and compositions. The second patent is centered around Pyridinyl substituted oxoisoindoline compounds. This patent describes compounds that can inhibit Helios protein, along with pharmaceutical compositions that consist of these compounds. These innovations are particularly relevant in the treatment of viral infections and proliferative disorders such as cancer.
Career Highlights
Satheesh has played pivotal roles in various organizations throughout his career. Notably, he has been associated with Bristol Myers Squibb Company, where he contributed to the development of advanced pharmaceutical innovations. His extensive experience in the industry has significantly bolstered his expertise in drug development and patenting.
Collaborations
Throughout his journey, Satheesh has collaborated with distinguished colleagues, including John T. Hynes and Venkatram Reddy Paidi. These collaborations have not only enhanced his research but also led to the advancement of innovative solutions in the pharmaceutical sector.
Conclusion
Satheesh Kesavan Nair exemplifies the spirit of innovation in the pharmaceutical industry through his patents and collaborative efforts. His work not only contributes to the scientific community but also holds promise for transforming healthcare through the development of effective therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile